The pharmaceutical industry (PI) is a principal provider of pharmacoeconomic (PE) data to health care organizations (HCOs). Therefore, assessing how this information is perceived and used by HCOs from the PI perspective can provide insights for future development of PE information. OBJECTIVES: The purpose of this study was to describe the PI perceptions regarding the use of PE information by HCOs. METHODS: A structured phone interview was conducted with PI personnel who routinely interact with HCOs, including account managers, scientific liaisons, and PE/outcomes research managers. Participants were asked to comment with regard to the frequency of use and importance of various types of PE information that is provided to HCOs. RESULTS: A total of 21 subjects were interviewed. About 95% stated that the PE information provided to HCOs in the previous year was helpful. The majority of respondents (76%) stated PE information was considered by HCOs for most or some decisions. There was significant variation when asked whether PE articles were relevant, credible, and understandable to HCOs. Reprints of PE data and HCO-specific information were most commonly listed as best-received by HCOs. A majority (81%) also felt there were barriers to using PE information in HCOs; isolated focus on the pharmacy budget was listed as the most common barrier. Only one-third of respondents felt their company met the PE needs of HCOs. The remainder listed lack of PE information as the primary cause for not meeting the PE needs of HCOs. CONCLUSION: While respondents felt that PE information is commonly used and is perceived as valuable, this study has identified potential limitations to the currently available information.